135
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases

, , , , , , & show all
Pages 129-139 | Published online: 05 Jan 2016

References

  • FranklinSSWongNDHypertension and cardiovascular disease: contributions of the Framingham heart studyGlobal Heart J2013814957
  • Burden: mortality, morbidity and risk factors Available from: www.who.int/nmh/publications/ncd_report_chapter1.pdfAccessed on July 28, 2015
  • ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003289192560257212748199
  • BorghiCRossiFRole of the Renin-Angiotensin-Aldosterone system and its pharmacological inhibitors in cardiovascular diseases: complex and critical issuesHigh Blood Press Cardiovasc Prev Epub9242015
  • SennesaelJVerbeelenDTherapeutic efficacy and tolerance of two orally active angiotensin converting enzyme inhibitors in patients undergoing regular hemodialysisKidney Int198528A252
  • DaviesMKGibbsCRLipGYHManagement: diuretics, ACE inhibitors, and nitratesBr Med J2000320723242843110669450
  • OsterzielKJJuliusSVasodilators in the treatment of hypertensionCompr Ther198281143526761057
  • BasnetPSkalko-BasnetNCurcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatmentMolecules2011164567459821642934
  • AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends Pharmacol Sci2009302859419110321
  • AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
  • KošťálováaDBezákovábLRačkovácLMošovskáaSŠturdíkETherapeutic potential of curcumin in medicinal chemistryActa Chim Slovaca2013618999
  • MengX-YZhangH-XMezeiMCuiMMolecular docking: a powerful approach for structure-based drug discoveryCurr Comput Aided Drug Des20117214615721534921
  • AhmadWKumolosasiEJantanIBukhariSNJasamaiMEffects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2, cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1Chem Biol Drug Des201483667068124406103
  • BukhariSNLauroGJantanIBifulcoGAmjadMWPharmacological evaluation and docking studies of α, β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and proinflammatory cytokinesBioorg Med Chem201422154151416124938495
  • BukhariSNJantanIUnsal TanOSherMNaeem-Ul-HassanMQinHLBiological activity and molecular docking studies of curcumin-related α, β-unsaturated carbonyl-based synthetic compounds as anticancer agents and mushroom tyrosinase inhibitorsJ Agric Food Chem201462245538554724901506
  • RingmanJMFrautschySAColeGMMastermanDLCummingsJLA potential role of the curry spice curcumin in Alzheimer’s diseaseCurr Alzheimer Res20052213113615974909
  • BukhariSNButtAMAmjadMWAhmadWShahVHTrivediARSynthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitorsPak J Biol Sci201316211368137224511749
  • AddlaDJallapallyAKanwalASridharBBanerjeeSKKantevariSDesign, synthesis and evaluation of novel 2-hydroxy-pyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitorsBioorg Med Chem201321154485449323777825
  • Skrzypiec-SpringMGrotthusBSzelągASchulzRIsolated heart perfusion according to Langendorff – still viable in the new millenniumJ Pharmacal Toxicol Meth200755113126